Abstract
Although courageous forays into the application of coronary artery bypass grafting (CABG) to the patient with advanced left ventricular dysfunction were made since the early davs of open heart surgery, the opinion that the patient with advanced left ventricular dysfunction could not and should not be offered coronary artery bypass surgery prevailed well into the 1980’s. The reluctance centered around three concerns: (1) that the risk of operation would be prohibitive, (2) that little symptomatic or longevity benefit would accrue from CABG, and (3) that CABG would merely punctuate an inevitable course of inexorable deterioration. Cardiologists were therefore reluctant to refer such patients for coronary revascularization and surgeons were reluctant to accept such patients. In terms of scientific evaluation, most large multicenter trials of coronary artery bypass grafting purposely excluded patients with advanced left ventricular dysfunction. (Ejection fraction was >35/a in the Coronary Artery Surgery Study (CASS) and >50% for the European Coronary Surgery Study (ECSS)).1,2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
CASS Principal Investigators. Coronary Artery Surgery Study (CASS): A randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983;68:939–50.
European Coronary Surgery Study Group. Long-term results of prospective randomized study or coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173–80.
Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211–3.
Franciosa JA, Wilen M, Ziesche S, et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831–6.
Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin 1989;7:1–9.
Louie HW, Laks H, Milgalter E, et al. Ischemic cardiomyopathy: Criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84[Suppl III]:III-290–III-295.
Christakis GT, Weisel RD, Fremes SE, et al. Coronary artery bypass grafting in patients with poor ventricular function. J Thoracic Cardiovasc Surg 1992;103:1083–92.
Lansman SL, Cohen M, Galla JD, et al. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Long-term follow-up. Ann Thorac Surg 1993;56:480–6.
Luciani GB, Faggian G, Razzolini R, et al. Severe ischemic vantricular failure: Coronary operation or heart transplantation? Ann Thorac Surg 1993;55:719–23.
Milano CA, White WD, Smith LR, et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993;56:487–93.
Langenberg SE, Buchanan SA, Blackboume LH, et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg 1995;60:1193–7.
Mickelborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92[Suppl II]:II-73–II-79.
Kaul TK, Agnihotri A, Fields B, et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 1996;111:1001–12.
Chan RK, Raman J, Lee KJ, et al. Prediction of outcome after revascularization in patients with poor left ventricular function. Ann Thorac Surg 1996;61:1428–34.
Hausmann H, Topp H, Siniawski H, Holz S, Hetzer R. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? Ann Thorac Surg 1997;64:1296–302.
Shapira I, Isakov A, Yakirevich V, Topilsky M. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 1995;108:1546–50.
Elefteriades JA, Morales DLS, Gradel C, et al. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions-30%. Am J Cardiol 1997;79:1573–8.
Elefteriades JA, Yepremyan M, Samady H, et al. Coronary Revascularization Outcomes. Plenary Sesion VII. 71st Annual Meeting of the American Heart Association, Dallas TX, November, 1998.
Elefteriades JA, Tolis G Jr, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411–7.
Dietl CA, Berkheimer MD, Woods EL, et al. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less. Ann Thorac Surg 1996;62:401–9.
Christenson JT, Badel P, Simonet F, Schmuziger M. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surgl 1997;64:1237–44.
Christenson JT, Simonet F, Badel P, Schmuziger M. Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg 1997;11:1097–104.
Baumgartner FJ, Oman BO, Goldberg S, et al. Coronary artery bypass grafting in patients with profound ventricular dysfunction. Tex Heart Inst J 1998;25:125–9.
Beller GA. Assessing prognosis by means of radionuclide perfusion imaging: What technique and which variables should be used. J Am Coll Cardiol 1998;31:1286–90.
Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation 1995;92:3436–44.
Dreyfus G, Duboc D, Blasco A, et al. Cororary surgery can be an alternative to heart transplantation in selected patients with end-stage ischemic heart disease. Eur J Cardiothorac Surg 1993;7:482–8.
Maddahi J, Blitz A, Phelps M, Laks H. The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy. Adv Card Surg 1996;7:163–88.
Kem JA, Kron IL. High-Risk Myocardial Revascularization. In: Rose EA, Stevenson LW (eds). Management of End-Stage Heart Disease. Lippincott-Raven. Philadelphia. 1998.
Blitz A, Scholl F, Laks H. Surgery for Chronic Heart Failure. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS (eds). Heart Failure, Churchill Livingstone. New York. 1997.
Kron IL, Cope JT, Baker LD, Spotnitz HM. The risks of reoperative coronry artery bypass in chronic ischemic cardiomyopathy: Results of the CABG Patch trial. Circulation 1997;96[Suppl II]:II-21–II-25.
Radovanovic N, Jakovljevic D. Long-term follow-up after different open-heart surgical procedures. In: Radovanovic N and Jakovljevic, New Approach and Methods for Evaluation of Results in Cardiac Surgery—A Research Study. Institute of Cardiovascular Diseases. Novi Sad, Yugoslavia, 1998.
Pagani FD, Bolling SF. Valve surgery in patients with severe left ventricular dysfunction. In: Rose EA, Stephenson LW (eds.). Management of End-Stage Heart Disease. Lippincott-Raven, Philadelphia 1998.
Kron IL. When does one replace the heart in ischemic cardiomyopathy? Ann Thorac Surg 1993;55:581–3.
Sanchez JA, Smith CR, Drusin RE, et al. High-risk reparative surgery: A neglected alternative to heart transplantation. Circulation 1990;82 [Suppl IV]:302–5.
Blakeman BM, Pifarre R, Sullivan H, et al. High-risk heart surgery in the heart transplant candidate. J Heart Transplant 1990;9:468–72.
Chan RK, Raman J, Lee KJ, et al. Prediction of outcome after revascularization in patients with poor left ventricular function. Ann Thor Surg 1996;61:1428–34.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers
About this chapter
Cite this chapter
Elefteriades, J.A. et al. (1999). Coronary artery bypass for advanced left ventricular dysfunction. In: Masters, R.G. (eds) Surgical Options for the Treatment of Heart Failure. Developments in Cardiovascular Medicine, vol 225. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-29191-8_2
Download citation
DOI: https://doi.org/10.1007/978-0-585-29191-8_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6130-5
Online ISBN: 978-0-585-29191-8
eBook Packages: Springer Book Archive